Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Prot #849-002: A Phase 1/2 Trial of MRTX849 in Combination with TNO155 in Patients with Advanced Solid Tumors with KRAS G12C Mutation
Mohindra, Nisha Anjali
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
9/10/20
→
9/10/23
Funding
Pharmaceutical Research Associates, Inc.
(Prot #849-002)
Mirati Therapeutics Inc.
(Prot #849-002)
View all
View less